Performance of a Real Time PCR for Pneumocystis jirovecii Identification in Induced Sputum of AIDS Patients: Differentiation between Pneumonia and Colonization
- PMID: 35330224
- PMCID: PMC8950466
- DOI: 10.3390/jof8030222
Performance of a Real Time PCR for Pneumocystis jirovecii Identification in Induced Sputum of AIDS Patients: Differentiation between Pneumonia and Colonization
Abstract
Pneumocystis jirovecii pneumonia (PcP) remains an important cause of morbimortality worldwide and a diagnostic challenge. Conventional methods have low accuracy, hardly discriminating colonization from infection, while some new high-cost or broncho-alveolar lavage-based methods have limited usefulness in developing countries. Quantitative PCR (qPCR) tests may overcome these limitations due to their high accuracy, possibility of automation, and decreasing cost. We evaluated an in-house qPCR targeting the fungus mtSSU gene using induced sputum. Sensitivity of the assay (ten target gene copies/assay) was determined using recombinant plasmids. We prospectively studied 86 AIDS patients with subacute respiratory symptoms in whom PcP was suspected. qPCR results were determined as quantification cycles (Cq) and compared with a qualitative PCR performed in the same IS, serum 1,3-β-D-Glucan assay, and a clinical/laboratory/radiology index for PcP. The qPCR clustered the patients in three groups: 32 with Cq ≤ 31 (qPCR+), 45 with Cq ≥ 33 (qPCR-), and nine with Cq between 31-33 (intermediary), which, combined with the other three analyses, enabled us to classify the groups as having PcP, not P. jirovecii-infected, and P. jirovecii-colonized, respectively. This molecular assay may contribute to improve PcP management, avoiding unnecessary treatments, and our knowledge of the natural history of this infection.
Keywords: 1,3-β-D-glucan; HIV/AIDS; Pneumocystis jirovecii; molecular diagnosis; real time PCR.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.Clin Microbiol Infect. 2012 Jun;18(6):591-7. doi: 10.1111/j.1469-0691.2011.03605.x. Epub 2011 Oct 4. Clin Microbiol Infect. 2012. PMID: 21973089
-
Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.J Clin Microbiol. 2013 Oct;51(10):3380-8. doi: 10.1128/JCM.01554-13. Epub 2013 Jul 31. J Clin Microbiol. 2013. PMID: 23903553 Free PMC article.
-
Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.Radiol Oncol. 2020 May 28;54(2):221-226. doi: 10.2478/raon-2020-0028. Radiol Oncol. 2020. PMID: 32463392 Free PMC article.
-
The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis.Med Mycol. 2021 Jul 14;59(8):802-812. doi: 10.1093/mmy/myab002. Med Mycol. 2021. PMID: 33578417 Free PMC article.
-
Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults.Expert Opin Med Diagn. 2013 Jan;7(1):85-97. doi: 10.1517/17530059.2012.722080. Epub 2012 Oct 18. Expert Opin Med Diagn. 2013. PMID: 23530845 Review.
Cited by
-
Diagnostic Approach to Pneumonia in Immunocompromised Hosts.J Clin Med. 2025 Jan 9;14(2):389. doi: 10.3390/jcm14020389. J Clin Med. 2025. PMID: 39860395 Free PMC article. Review.
-
Study on mNGS Technique in Diagnosing Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients.Infect Drug Resist. 2024 Apr 11;17:1397-1405. doi: 10.2147/IDR.S450878. eCollection 2024. Infect Drug Resist. 2024. PMID: 38628239 Free PMC article.
-
Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids.Microbiol Spectr. 2023 Aug 17;11(4):e0102123. doi: 10.1128/spectrum.01021-23. Epub 2023 Jun 1. Microbiol Spectr. 2023. PMID: 37260378 Free PMC article.
-
Predictive models-assisted diagnosis of AIDS-associated Pneumocystis jirovecii pneumonia in the emergency room, based on clinical, laboratory, and radiological data.Sci Rep. 2024 May 16;14(1):11247. doi: 10.1038/s41598-024-61174-4. Sci Rep. 2024. PMID: 38755293 Free PMC article.
-
Global prevalence, mortality, and main characteristics of HIV-associated pneumocystosis: A systematic review and meta-analysis.PLoS One. 2024 Mar 25;19(3):e0297619. doi: 10.1371/journal.pone.0297619. eCollection 2024. PLoS One. 2024. PMID: 38526997 Free PMC article.
References
-
- Ford N., Shubber Z., Meintjes G., Grinsztejn B., Eholie S., Mills E.J., Davies M.-A., Vitoria M., Penazzato M., Nsanzimana S., et al. Causes of Hospital Admission among People Living with HIV Worldwide: A Systematic Review and Meta-Analysis. Lancet HIV. 2015;2:e438–e444. doi: 10.1016/S2352-3018(15)00137-X. - DOI - PubMed
-
- Kaplan J.E., Hanson D., Dworkin M.S., Frederick T., Bertolli J., Lindegren M.L., Holmberg S., Jones J.L. Epidemiology of Human Immunodeficiency Virus-Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy. Clin. Infect. Dis. 2000;30:S5–S14. doi: 10.1086/313843. - DOI - PubMed
-
- Rojanawiwat A., Tsuchiya N., Pathipvanich P., Pumpradit W., Schmidt W.-P., Honda S., Auwanit W., Sawanpanyalert P., Ariyoshi K. Impact of the National Access to Antiretroviral Program on the Incidence of Opportunistic Infections in Thailand. Int. Health. 2011;3:101–107. doi: 10.1016/j.inhe.2010.12.004. - DOI - PubMed
LinkOut - more resources
Full Text Sources